- The effect of the oral iron chelator deferiprone on the liver damage induced by tamoxifen in female rats2011 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial2017 | 2. lékařská fakulta
- Safety of intravenous ferric carboxymaltose versus oral iron in patients with non-dialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial2017 | 2. lékařská fakulta
- The effect of the oral iron chelator deferiprone on the liver damage induced by tamoxifen in female rats2009 | Lékařská fakulta v Plzni
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | 1. lékařská fakulta
- Erythropoietin administration may potentiate mobilization of storage iron in patients on oral iron chelation therapy2006 | 1. lékařská fakulta
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | Publikace bez příslušnosti k fakultě
- Je intravenózní aplikace železa u nemocných s CKD výhodnější než perorální podání? Výsledky studie REVOKE : Komentář2016 | 1. lékařská fakulta
- Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats2016 | 1. lékařská fakulta
- Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial2017 | 2. lékařská fakulta
- The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method2013 | 1. lékařská fakulta
- Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients2021 | 1. lékařská fakulta